Assessing the effects of grapes and grape powder extracted polyphenols on lipogenesis and glucose uptake in adipocytes may clarify the risk/benefit of recommending them to individuals with obesity and insulin resistance. We investigated the effect of grape powder extracted polyphenols (GPEP) on intracellular fat accumulation and glucose uptake during differentiation of 3T3-F442A preadipocytes. Total polyphenols were extracted and measured based on gallic acid equivalents (GAE). There were 2167 mg of GAE polyphenols in 100 g of grape powder. 3T3-F442A cells were incubated with GPEP, extracted from 125–500 µg GP/mL of media, until day 8 of differentiation when the cells were collected for different assays. AdipoRed™ assay and Oil Red O staining showed that GPEP induced, in a dose-dependent manner, an increase in intracellular triacylglycerol (TAG) content of adipocytes. Concomitantly, grape powder extracted polyphenols increased, in a dose-dependent manner, glucose uptake by 3T3-F442A cells, and there was a strong positive correlation between glucose uptake and the amount of TAG accumulation (r = 0.826, n = 24, P ≤ 0.001). No changes in cell viability was measured by Trypan Blue staining, suggesting that these effects were independent of cytotoxicity. Western-blot showed that GPEP upregulated protein level of glucose transport protein 4 (GLUT4), p-PKB/Akt, and p-AMPK in 3T3-F442A adipocytes. LY294002 (10 µmol/L), a phosphatidyl-inositol 3 kinase inhibitor (PI3K), reversed the effects of grape powder extracted polyphenols on cellular lipid content and glucose uptake. Furthermore, quantitative real-time polymerase chain reaction showed that GPEP increased mRNA expression of GLUT4, fatty acid synthase, lipoprotein lipase, adiponectin, and peroxisome proliferator-activated receptor γ, while it decreased mRNA expression of leptin and Insig-1. Our results indicate that GPEP may induce adipocyte differentiation via upregulation of GLUT4, PI3K and adipogenic genes. Future research may be directed toward obese individuals with insulin resistance or individuals with diabetes.
BurdiARPoissonnetCMGarnSMLavelleMSabetMDBridgesP. Adipose tissue growth patterns during human gestation: a histometric comparison of buccal and gluteal fat depots. Int J Obes1985; 9: 247–56.
2.
MacDougaldOALaneMD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem1995; 64: 345–73.
3.
SpiegelmanBMGintyCA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell1983; 35: 657–66.
4.
SpaldingKLArnerEWestermarkPOBernardSBuchholzBABergmannOBlomqvistLHoffstedtJNäslundEBrittonTConchaHHassanMRydénMFrisénJArnerP. Dynamics of fat cell turnover in humans. Nature2008; 453: 783–7.
5.
PrinsJBO’RahillyS. Regulation of adipose cell number in man. Clin Sci1997; 92: 3–11.
6.
UngerRH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes1995; 44: 863–8.
7.
UngerRHZhouYT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes2001; 50: S118–21.
8.
UngerRHOrciL. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J2001; 15: 312–21.
TangQQLaneMD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem2012; 81: 715–36.
11.
GreenHKehindeO. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell1975; 5: 19–27.
12.
Kuri-HarcuchWGreenH. Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci U S A1978; 75: 6107–9.
13.
RosenOMSmithCJFungCRubinCS. Development of hormone receptors and hormone responsiveness in vitro, Effect of prolonged insulin treatment on hexose uptake in 3T3-L1 adipocytes. J Biol Chem1978; 253: 7579–83.
14.
ZezulakKMGreenH. The generation of insulin-like growth factor-1 – sensitive cells by growth hormone action. Science1986; 233: 551–3.
15.
Torabi S, Mo H. Trans, trans-farnesol as a mevalonate-derived inducer of murine 3T3-F442A pre-adipocyte differentiation. Exp Biol Med (Maywood). Epub ahead of print 8 December 2015. DOI: 1535370215620855.
RadhakrishnanAGoldsteinJLMcDonaldJGBrownMS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab2008; 8: 512–21.
GreenHKehindeO. Sublines of mouse 3T3 cells that accumulate lipid. Cell1974; 1: 113–6.
20.
KulikGKlippelAWeberMJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol1997; 17: 1595–606.
21.
WangQSomwarRBilanPJLiuZJinJWoodgettJRKlipA. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol1999; 19: 4008–18.
22.
IshikiMRandhawaVKPoonVJebaileyLKlipA. Insulin regulates the membrane arrival, fusion, and C-terminal unmasking of glucose transporter-4 via distinct phosphoinositides. J Biol Chem2005; 280: 28792–802.
23.
BlairLABence-HanulecKKMehtaSFrankeTKaplanDMarshallJ. Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival. J Neurosci1999; 19: 1940–51.
24.
BarberAJNakamuraMWolpertEBReiterCESeigelGMAntonettiDAGardnerTW. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem2001; 276: 32814–21.
25.
PeruzziFPriscoMDewsMSalomoniPGrassilliERomanoGCalabrettaBBasergaR. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol1999; 19: 7203–15.
26.
TomiyamaKNakataHSasaHArimuraSNishioEWatanabeY. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun1995; 212: 263–9.
27.
XuJLiaoK. Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem2004; 279: 35914–22.
28.
PengXDXuPZChenMLHahn-WindqassenASkeenJJacobsJSundararajanDChenWSCrawfordSEColemanKGHayN. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev2003; 17: 1352–65.
29.
OvermanABumrungpertAKennedyAMartinezKChuangCWestTDawsonBJiaWMcIntoshM. Polyphenol-rich grape powder extract (GPE) attenuates inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. Internat J Obes (Lond)2010; 34: 800–8.
30.
Ramírez-ZacaríasJLCastro-MuñozledoFKuri-HarcuchW. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry1992; 97: 493–7.
31.
KimDOChunOKKimYJMoonHYLeeCY. Quantification of polyphenolics and their antioxidant capacity in fresh plums. J Agric Food Chem2003; 51: 6509–15.
32.
GreenspanPMayerEPFowlerSD. Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol1985; 100: 965–73.
33.
ElfakhaniMTorabiSHusseinDMillsNVerbeckGMoH. Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes. Exp Biol Med (Maywood)2014; 239: 293–301.
34.
OvermanAChuangCCMcIntoshM. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media. Int J Obes (Lond)2011; 35: 1165–72.
35.
ChuangCCMartinezKXieGKennedyABumrungpertAOvermanAJiaWMcIntoshMK. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr2010; 92: 1511–21.
36.
ChuangCCShenWChenHXieGJiaWChungSMcIntoshMK. Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fat-fed obese mice. J Agric Food Chem2012; 60: 12458–68.
37.
HeALiuXLiuLChangYFangF. How many signals impinge on GLUT4 activation by insulin?Cell Signal2007; 19: 1–7.
38.
TontonozPHuEGravesRABudavariAISpiegelmanBM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev1994; 8: 1224–34.
39.
LiaoZWuZWuM. Cirsium japonicum flavones enhance adipocyte differentiation and glucose uptake in 3T3-L1 cells. Biol Pharm Bull2012; 35: 855–60.
40.
AsterholmIWSchererPE. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol2010; 176: 1364–76.
41.
LehmannJMMooreLBSmith-OliverTAWilkisonWOWillsonTMKliewerSA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem1995; 270: 12953–6.
42.
BarrosoIGurnellMCrowleyVEAgostiniMSchwabeJWSoosMAMaslenGLWilliamsTDLewisHSchaferAJChatterjeeVKO'RahillyS. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature1999; 402: 880–3.
43.
AgostiniMSchoenmakersEMitchellCSzatmariISavageDSmithARajanayagamOSempleRLuanJBathLZalinALabibMKumarSSimpsonHBlomDMaraisDSchwabeJBarrosoITrembathRWarehamNNagyLGurnellMO'RahillySChatterjeeK. Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell Metab2006; 4: 303–11.
44.
HeWBarakYHevenerAOlsonPLiaoDLeJNelsonMOngEOlefskyJMEvansRM. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A2003; 100: 15712–7.
45.
BouskilaMPajvaniUBSchererPE. Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity. Int J Obes (Lond)2005; 29(Suppl 1): S17–23.
46.
HuELiangPSpiegelmanB. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem1996; 271: 10697–703.
47.
FriedmanJMHalaasJL. Leptin and the regulation of body weight in mammals. Nature1998; 395: 763–70.
48.
ElmquistJKMaratos-FlierESaperCBFlierJS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci1998; 1: 445–49.
49.
MontagueCTFarooqiISWhiteheadJPSoosMARauHWarehamNJSewterCPDigbyJEMohammedSNHurstJACheethamCHEarleyARBarnettAHPrinsJBO'RahillyS. Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature1997; 387: 903–8.
50.
LiJTakaishiKCookWMcCorkleSKUngerRH. “Insig-1 “brakes” lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc Natl Acad Sci U S A2003; 100: 9476–8.
51.
YangTEspenshadePJWrightMEYabeDGongYAebersoldRGoldsteinJLBrownMS. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell2002; 110: 489–500.
52.
TontonozPKimJBGravesRASpigelmanBM. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol1993; 13: 4753–59.
53.
HardieDG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol2007; 8: 774–85.
54.
ChavezJARoachWGKellerSRLaneWSLienhardGE. Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating Protein abundant in skeletal muscle, is partially relieved by amp-activated protein kinase activation. J Biol Chem2008; 283: 9187–95.
55.
HuangSCzechMP. The GLUT4 glucose transporter. Cell Metab2007; 5: 237–52.
56.
SanoHEguezLTeruelMNFukudaMChuangTDChavezJA. Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab2007; 5: 293–303.
57.
EguezLLeeAChavezJAMiineaCPKaneSLienhardGEMcGrawTE. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab2005; 2: 263–72.
58.
LaranceMRammGStöckliJvan DamEMWinataSWasingerVSimpsonFGrahamMJunutulaJRGuilhausMJamesDE. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem2005; 280: 37803–13.
59.
ParkSYKimMHAhnJHLeeSJLeeJHEumWSChoiSYKwonHY. The stimulatory effect of essential fatty acids on glucose uptake involves both Akt and AMPK activation in C2C12 skeletal muscle cells. Korean J PhysiolPharmacol2014; 18: 255–61.
60.
KristensenJMTreebakJTSchjerlingPGoodyearLWojtaszewskiJF. Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin stimulated glucose uptake in mouse soleus muscle. Am J Physiol Endocrinol Metab2014; 306: 1099–109.
61.
JiLZhangXLiuWHuangQYangWFuFMaHSuHWangHWangJZhangHGaoF. AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury. PLoS One2013; 8: e69910–e69910.
62.
UedaMHayashibaraKAshidaH. Propolis extract promotes translocation of glucose transporter 4 and glucose uptake through both PI3K- and AMPK-dependent pathways in skeletal muscle. Biofactors2013; 39: 457–466.
63.
PoulosSPDodsonMVHausmanGJ. Cell line models for differentiation: preadipocytes and adipocytes. Exp Biol Med (Maywood)2010; 235: 1185–93.
